French firm's drug succeeds in pivotal trial for progressive MS
April 17, 2015 at 04:00 AM EDT
LONDON, April 17 (Reuters) - An experimental drug comprising of a high-dose formulation of the food additive biotin has successfully helped patients with progressive multiple sclerosis in a major clinical trial, its French maker said on Friday.
